Russell Investments Group Ltd. Sells 114,231 Shares of Oscar Health, Inc. $OSCR

Key Points

• Russell Investments Group Ltd. has significantly reduced its stake in Oscar Health by 52.7%, owning 102,551 shares worth approximately $1.34 million after selling more than 114,000 shares in the first quarter.
• Several other institutional investors, including Southeastern Asset Management and Man Group plc, have increased their positions in Oscar Health, indicating a mixed sentiment among institutional investors.
• Oscar Health has faced downgrades from multiple analysts recently, with an average rating of "Strong Sell" and a price target that has been reduced to around $12.07.

Russell Investments Group Ltd. lessened its stake in shares of Oscar Health, Inc. (NYSE:OSCR - Free Report) by 52.7% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 102,551 shares of the company's stock after selling 114,231 shares during the period. Russell Investments Group Ltd.'s holdings in Oscar Health were worth $1,344,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Southeastern Asset Management Inc. TN grew its holdings in Oscar Health by 52.2% during the fourth quarter. Southeastern Asset Management Inc. TN now owns 3,131,084 shares of the company's stock valued at $42,082,000 after purchasing an additional 1,073,359 shares during the last quarter. Jacobs Levy Equity Management Inc. grew its holdings in Oscar Health by 37.8% during the fourth quarter. Jacobs Levy Equity Management Inc. now owns 1,741,306 shares of the company's stock valued at $23,403,000 after purchasing an additional 477,634 shares during the last quarter. Man Group plc grew its holdings in Oscar Health by 344.8% during the fourth quarter. Man Group plc now owns 1,813,216 shares of the company's stock valued at $24,370,000 after purchasing an additional 1,405,554 shares during the last quarter. Victory Capital Management Inc. grew its holdings in Oscar Health by 23.8% during the first quarter. Victory Capital Management Inc. now owns 285,997 shares of the company's stock valued at $3,749,000 after purchasing an additional 54,938 shares during the last quarter. Finally, Toronto Dominion Bank acquired a new position in Oscar Health during the fourth quarter valued at approximately $1,008,000. Institutional investors and hedge funds own 75.70% of the company's stock.

Oscar Health Price Performance

Shares of NYSE OSCR traded down $0.59 during midday trading on Monday, reaching $16.66. 9,548,309 shares of the company traded hands, compared to its average volume of 18,137,728. The firm has a market cap of $4.31 billion, a PE ratio of -20.56 and a beta of 1.87. The stock's 50-day simple moving average is $16.02 and its 200-day simple moving average is $14.90. Oscar Health, Inc. has a 12 month low of $11.20 and a 12 month high of $23.79. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.86 and a current ratio of 0.86.

Oscar Health (NYSE:OSCR - Get Free Report) last issued its quarterly earnings data on Wednesday, August 6th. The company reported ($0.89) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.90) by $0.01. The company had revenue of $2.86 billion during the quarter, compared to analysts' expectations of $2.88 billion. Oscar Health had a negative return on equity of 13.78% and a negative net margin of 1.50%.The business's revenue was up 29.0% on a year-over-year basis. During the same period last year, the business earned $0.20 earnings per share. As a group, equities analysts anticipate that Oscar Health, Inc. will post 0.69 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities analysts have commented on OSCR shares. Piper Sandler lowered their price target on Oscar Health from $14.00 to $13.00 and set a "neutral" rating on the stock in a report on Thursday, August 14th. Robert W. Baird restated a "neutral" rating and issued a $14.00 price objective (down previously from $28.00) on shares of Oscar Health in a research note on Friday, July 25th. Baird R W downgraded shares of Oscar Health from a "strong-buy" rating to a "hold" rating in a research note on Friday, July 25th. UBS Group restated a "sell" rating and issued a $11.00 price objective (down previously from $15.00) on shares of Oscar Health in a research note on Tuesday, July 15th. Finally, Wall Street Zen downgraded shares of Oscar Health from a "hold" rating to a "sell" rating in a research note on Saturday, August 9th. Four equities research analysts have rated the stock with a Hold rating and five have given a Sell rating to the company's stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Strong Sell" and a consensus price target of $12.07.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.